MT-ND4 and pneumocystosis: CRISPR Nad4 assay results from adult BAL and serum samples also had better performance to distinguish adult PCP and non-PCP cases than matching Gsc1 assay results when both were evaluated by ROC curve analysis (Supplemental Figure 7).